3.314.0
Nov 14, 2026
• Changes in bedaquiline, cefazolin, cefepime, favipiravir, fosmanogepix, linezolid, quinolones. Actinomadura, Curtobacterium, M. leprae, M. tuberculosis, M. pneumoniae, Nocardia, Proteus, S. aureus, S. agalactiae, S. suis, Streptomyces, viridans group streptococcus; Aspergillus, Candida, Paracoccidioides; HBV, LCMV, MARV, Orthohantavirus; Mesocestoides. Acute meningitis. Mycetoma. Other entries.<
3.312.0
Oct 31, 2026 · seen Nov 4, 2026
• Added the PACTO risk score for IE.<br>• Changes in fosmanogepix, meropenem, oseltamivir. CoNS, Enterococcus, Helicobacter, Ignatzschineria, Spiroplasma, S. aureus, S. agalactiae; Candida, C. neoformans, Diaporthe, Exophiala; HCV, HEV, hMPV, Orthobunyavirus, RSV; C. cayetanensis, Strongyloides. Arthropod-borne infections. Encephalitis. Infections of the spine. Infective endocarditis. Neutropenic
3.311.0
Oct 24, 2026
Changes in bepirovirsen, cefiderocol, ceftolozane/tazobactam, ethambutol, islatravir, levofloxacin, monoclonal antibodies, pritelivir, rifapentine, vancomycin. B. cepacia, Kerstersia, M. tuberculosis, nontuberculous mycobacteria, Pandoraea, Shigella, Stenotrophomonas, viridans group streptococci; Candida; Alphavirus, bunyavirus, dengue, EBV, HIV, measles, OROV, Orthobunyavirus. Allergy to antibiot
3.307.0
Sep 26, 2026
Changes in amphotericin B deoxycholate, caspofungin, ceftobiprole, fosfomycin, linezolid, omadacycline, pritelivir, rifabutin. Acinetobacter, Borrelia burgdorferi, Clostridioides difficile, CoNS, Enterococcus, Helicobacter, Leptospira; Aspergillus, Candida, Coccidioides, Histoplasma, Lomentospora, Pneumocystis jirovecii, Pythium; HSV-1 and HSV-2, SARS-CoV-2. Encephalitis. Fever without an apparent